# Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)

> **NCT00907478** · PHASE4 · COMPLETED · sponsor: **Amgen** · enrollment: 169 (actual)

## Conditions studied

- Thrombocytopenia
- Idiopathic Thrombocytopenic Purpura

## Interventions

- **BIOLOGICAL:** romiplostim

## Key facts

- **NCT ID:** NCT00907478
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-11
- **Primary completion:** 2014-01-09
- **Final completion:** 2014-01-14
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00907478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00907478, "Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00907478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*